Skip to main content
. 2020 Sep 15;286:113972. doi: 10.1016/j.jviromet.2020.113972

Table 4.

Validation of dual-target RT-LAMP (S and RdRP genes) using a validation set of clinical samples. PPA - positive percent agreement; NPA - negative percent agreement.

RT-LAMP (S and RdRP gene) RT-PCR (E and N2 gene)
Total
Positive Negative
Positive 65 0 65
Negative 1 58 59
Total 66 58 124
PPA 98.48 % (95 % CI 91.84%–99.96%)
NPA 100.00 % (95 % CI 93.84%–100.00%)